- Home
- IPHA vs EPM Comparison
IPHA vs EPM Comparison
Compare IPHA & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- EPM
- Stock Information
- Founded
- IPHA 1999
- EPM 2003
- Country
- IPHA France
- EPM United States
- Employees
- IPHA N/A
- EPM N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- EPM Oil & Gas Production
- Sector
- IPHA Health Care
- EPM Energy
- Exchange
- IPHA Nasdaq
- EPM Nasdaq
- Market Cap
- IPHA 187.0M
- EPM 171.8M
- IPO Year
- IPHA 2019
- EPM 1996
- Fundamental
- Price
- IPHA $2.30
- EPM $4.70
- Analyst Decision
- IPHA Strong Buy
- EPM Strong Buy
- Analyst Count
- IPHA 1
- EPM 1
- Target Price
- IPHA $11.50
- EPM $8.25
- AVG Volume (30 Days)
- IPHA 5.6K
- EPM 245.1K
- Earning Date
- IPHA 09-12-2024
- EPM 09-10-2024
- Dividend Yield
- IPHA N/A
- EPM 10.15%
- EPS Growth
- IPHA N/A
- EPM N/A
- EPS
- IPHA N/A
- EPM 0.08
- Revenue
- IPHA $68,134,188.00
- EPM $82,824,000.00
- Revenue This Year
- IPHA N/A
- EPM N/A
- Revenue Next Year
- IPHA $105.84
- EPM $22.21
- P/E Ratio
- IPHA N/A
- EPM $61.30
- Revenue Growth
- IPHA 6.88
- EPM N/A
- 52 Week Low
- IPHA $1.81
- EPM $4.66
- 52 Week High
- IPHA $3.15
- EPM $9.34
- Technical
- Relative Strength Index (RSI)
- IPHA 52.64
- EPM 32.69
- Support Level
- IPHA $2.14
- EPM $5.05
- Resistance Level
- IPHA $2.35
- EPM $5.23
- Average True Range (ATR)
- IPHA 0.15
- EPM 0.12
- MACD
- IPHA 0.00
- EPM -0.03
- Stochastic Oscillator
- IPHA 58.82
- EPM 1.75
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent oil and gas company operating in the US. It is engaged primarily in the acquisition, exploitation, and development of properties for the production of crude oil and natural gas, onshore in the United States. The company's revenues are primarily generated from its crude oil, natural gas and NGL production from the Jonah Field in Sublette County, Wyoming; the Williston Basin in North Dakota; the Barnett Shale located in North Texas; the Hamilton Dome Field in Wyoming; and the Delhi Field in Northeast Louisiana. The revenue generated by the company includes royalty, mineral and working interests.